Our group is interested in better understanding the mechanisms that promote bony bar formation, such as angiogenesis and osteogenesis, and how we can use that knowledge to develop technologies that would prevent bony repair tissue. We have a long-standing collaboration with Dr. Melissa Krebs at the Colorado School of Mines, where drug delivery systems developed in her lab are used to deliver anti-angiogenic or anti-osteogenic factors (antibodies and siRNA) in our animal models of growth plate injury.